229 event(s) found
ASTRO 2026 - Data to Dialogue: Communicating Radiotherapy's Value to Advance Care
the event of the year for the radiation oncology community! Additional details will be added as they become available, so please check back!
Translational Cancer Research for Basic Scientists Workshop
Join us for an intensive week-long introduction to translational cancer research, tailored for basic scientists who are predoctoral students, postdoctoral fellows, early-career scientists, and senior scientists transitioning to translational research. The Translational Cancer Research for Basic Scientists Workshop equips participants with crucial skills to align their research with clinical applications and embark on careers in translational cancer medicine. Throughout the week, attendees will immerse themselves in the latest methodologies and approaches of cutting-edge translational cancer research, led by prominent scientists from academia, government, and industry. This dynamic workshop covers various aspects of translational research, including interdisciplinary collaboration, effective engagement with industry partners, understanding the clinical environment and its unique requirements, and navigating regulatory and compliance challenges in translational science. Moreover, this program emphasizes the importance of grasping the perspectives of both patients and clinicians, enabling basic scientists to contextualize their research inquiries within a broader framework. We are thrilled to offer this exceptional educational opportunity once again, aimed at fostering the professional growth of early-career investigators in the field of translational cancer research.
2026 Global Cardio-Oncology Summit (GC-OS)
GC-OS is the premier international, interdisciplinary event dedicated to advancing the prevention and management of cardiovascular disease among cancer survivors. Our theme for 2026 will be “Cardio-Oncology Innovation and Implementation for the Future,” and topics will include: The intersection between artificial intelligence and cardio-oncology New treatments for cardiac amyloidosis Cardiac imaging: novel surveillance strategies and integrative & multimodality imaging Preventive therapy and exercise interventions for cardio-toxicity Next generation therapies in hematology and oncology Role of the immune system in cancer and cardiovascular disease
2nd Australasian International Breast Congress
2nd Australasian International Breast Congress organized by ASBD; CoBrCa; BreastSurgANZ
SOHO Central Europe 2026
SOHO-Central Europe is honored to present the first satellite meeting in Budapest in 2026, extending SOHO’s educational mission to additional regions around the world. All SOHO members gain access to worldwide educational resources when they join SOHO FREE of charge.
Drug Discovery 2026
More information coming soon…
BRAIN METS 2026 – 13th Brain Metastases Conference
A leading European meeting dedicated to advancing research and clinical care in brain and spine metastases. Focus: Multidisciplinary collaboration across medical oncology, neurosurgery, radiation oncology, neuro-oncology, imaging, pathology, and translational research. Goal: Accelerate progress from scientific discovery to clinical impact, while strengthening European and international partnerships as the meeting transitions toward EuroBM.
SOHO France Annual Congress
In French: "Pour cette cinquième édition à venir, retrouvez 35 thématiques en seulement 72h ! Cette conférence annuelle reprend le concept du SOHO américain organisé par le MD Anderson à Houston depuis 13 ans. Avec le soutien des fondateurs du SOHO américain, le congrès français rassemblera un panel d’experts autour de 10 pathologies de l’hématologie. Découvrez le programme, les orateurs et faites partis des privilégiés qui prennent part à ce grand évènement unique en France !"
19th AACR Conference on The Science of Cancer Health Disparities
Join us at the 19th AACR Conference on The Science of Cancer Health Disparities, where cutting-edge cancer research meets real-world solutions. This conference is dedicated to advancing the understanding of cancer health disparities that pose significant public health challenges and disproportionately affect vulnerable communities. Engage with experts in basic, translational, clinical, population, behavioral, computational, and community-based research. Conference participants will have the opportunity to exchange ideas, discuss new findings, and build new research collaborations focused on eliminating cancer health disparities and creating a healthier future for all.
ESMO Congress 2026
The ESMO Congress is a highly influential global oncology meeting for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2026 will be a platform for breakthroughs in oncology research, clinical practice and patient care. Participants can expect impactful new data, interactive education, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale.
IOCHe2026 – 1st International Online Conference on Hematology
The 1st International Online Conference on Hematology (IOCHe2026)—organized by the MDPI journals Hemato, Hematology Reports, and Thalassemia Reports—will bring together researchers to share the latest developments in the field, from anemia and transfusion medicine to leukemia and rare blood disorders. Participants are encouraged to present their work and engage with colleagues worldwide. Registration and abstract submission are free of charge.
ELRIG’s French Forum: Single cell and spatial biology
Single-cell technologies integrated with spatial biology are transforming drug discovery and our understanding of human biology by revealing how cellular diversity, state, and microenvironment drive health and disease. Together, these approaches enable precise target identification and validation by linking molecular mechanisms to specific cell contexts. They expose the cellular ecosystems underlying complex diseases, uncover drivers of resistance and adverse events, and guide design of modality-appropriate interventions that act on the right cells in the right locations. Integration of single-cell and spatial readouts will yield actionable, mechanistic maps of human tissues, accelerating translation from target discovery to clinical impact. This forum will explore the recent advances that are driving this explosion in understanding whilst showcasing the impact it is having.
AORTIC 2027
Stay tuned for more details...
47èmes Journées de la SFSPM : Comment intégrer l’intelligence artificielle dans la prise en charge des cancers du sein : défis et perspectives
in French: "Les Journées de la SFSPM représentent un rendez-vous incontournable pour les professionnels de santé et les chercheurs impliqués dans la prévention, le diagnostic, et le traitement des pathologies mammaires. Organisé chaque année, cet événement scientifique et médical réunit des experts de diverses disciplines de la sénologie."
COSA Annual Scientific Meeting 2026
COSA Annual Scientific Meeting 2026 organized by Clinical Oncology Society of Australia (COSA)
Frontiers in Cancer Science 2026
Multidisciplinary conference presenting cutting-edge research in cancer biology and therapeutic strategies.
AAGL26: 55th Global Conference on MIGS
This year's meeting features an innovative program focused on minimally invasive gynecologic surgery with emphasis on cutting-edge technology and breakthrough research. The theme is "Empowering Women's Voices: Surgical Excellence, Digital Transformation & Outcomes-Driven Care - Advancing Awareness, Access & Autonomy Worldwide"
The Robert A. Winn Excellence In Clinical Trials Award Program: Design and Implementation of Clinical Trials Workshop
The Robert A. Winn Excellence in Clinical Trials: Career Development Award (Winn CDA), supported by the Bristol Myers Squibb Foundation, is a 2-year program designed to support the career development of early-stage investigator physicians who have a demonstrated commitment to transforming and expanding access to the clinical research landscape. They will become community-oriented clinical trialists who will drive improved health outcomes through their research and mentoring. Currently, our clinical research areas include cancer, cardiovascular disease and immunologic disorders. The Winn CDA offers a comprehensive and integrated approach to improving participation in clinical trials through workforce development and mentoring. The program kicks off with a virtual orientation in October and an in-person 4.5-5-day intensive workshop titled the Robert A. Winn Excellence in Clinical Trials: Design and Implementation of Clinical Trials in partnership with the American Association for Cancer Research® (Winn-AACR DICT Workshop) from November 17-21, 2025, in Albuquerque, NM. The workshop imparts essential knowledge about clinical trials design, development, implementation, and community engagement.
LEUKEMIA 360
The premier international meeting devoted to academia-industry leukemia R&D&I partnering. An event organized by OPALE, The Organization for Partnerships in Leukemia, supported by France's National Cancer Institute and the ARC Foundation for Cancer Research.
Protein Sciences in Drug Discovery 2026
More information coming soon…
CNRC 2026
In French : "Le Congrès National des Réseaux de Cancérologie (CNRC) est un événement annuel majeur dans le domaine de la cancérologie, réunissant plus de 500 experts nationaux & régionaux, acteurs de la coordination des parcours de soins, professionnels de santé, associations de patients et représentants de l’industrie. Il permet de partager des connaissances, d’échanger sur les dernières avancées en matière de coordination, et de favoriser la collaboration entre les différents acteurs impliqués dans la prise en charge de patients atteints de cancer."
38th ENA (EORTC-NCI-AACR) Symposium on Molecular Targets and Cancer Therapeutics
Recognised as a leading forum for drug development and translational research, ENA 2026 will spotlight cutting-edge preclinical and phase I studies, fostering deep scientific exchange around emerging targets and novel therapeutics. Bringing together a global community of researchers, clinicians, and industry experts, the Symposium offers a dynamic platform to explore the latest breakthroughs in molecular biology, target identification, and drug innovation.
AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer
Conference on liver cancer biology, immunotherapy, and translational research.
AACR Special Conference in Cancer Research: Cancer Biology-informed Radioligand Therapy
The goal of this conference is to convene experts in cancer biology, immunotherapy, and radioligand therapy (RLT) to discuss approaches to treating cancer with radioligand therapies and explore synergies with other treatments. With significant effort and interest in radioligand therapy by academia, industry, and government, paradigm-changing studies have demonstrated that combining molecular imaging and RLT has the possibility to dramatically impact cancer treatment. However, the major limitation for the further development of this field is a lack of fundamental knowledge of the mechanism(s) of action of systemic therapeutic isotopes with tumors, the tumor microenvironment, and the immune system. This conference is needed to engage experts from these diverse areas to not only educate on the state-of-the-art in radiotheranostics, but also to leverage the knowledge of cancer biologists, clinical oncologists, and immunologists to understand how RLT approaches work and how to overcome their limitations to drive the development of next generation therapies. Advancing RLT requires multi-disciplinary effort, with critical input from experts in radiochemistry, instrumentation, nuclear physics, and radiation biology. An unmet need in the field is advanced understanding of systemic radiobiology and cancer immunology as linked to therapeutic isotopes to fill gaps in knowledge across these domains. This AACR conference will focus on bringing together experts in these areas to discuss: 1) novel mechanisms of action of how systemic beta- and alpha-emitting isotopes interact with tumors, TME and the whole body to affect cures; 2) how RLT engages the immune system to mediate therapeutic efficacy; 3) rational approaches to treating cancer with novel isotopes and repurposed radioligand therapies; and 4) novel combinations and synergies with targeted and cellular therapies as well as external beam radiation, leveraging the strengths of each. Understanding how RLT interacts with the TME and the immune system are key to advancing novel therapies to treat an array of cancers.